中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 9
Sep.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(9): 2148-2152

Clinical features of patients with acute-on-chronic liver failure and bacterial infection and influencing factors for prognosis

DOI: 10.3969/j.issn.1001-5256.2021.09.028

  • Division of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China

  • Received Date: 2021-01-17
  • Accepted Date: 2021-02-03
  • Published Date: 2021-09-20
    Abstract
  •   Objective  To investigate the clinical features of infection in patients with acute-on-chronic liver failure (ACLF) and bacterial infection and the influencing factors for 90-day survival rate.  Methods  The patients with ACLF who were admitted to The Fifth Medical Center of Chinese PLA General Hospital from January 2014 to December 2015 were enrolled, and related clinical data were collected and analyzed, including infection time and site, microbial culture, biochemical parameters and inflammatory markers, and 28- and 90-day prognosis after infection. The t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. The life-table method was used to plot survival curves. The indices affecting prognosis in the univariate analysis were further included in the multivariate logistic regression analysis.  Results  A total of 1074 patients with ACLF were admitted, among whom 609 had bacterial infection, and the incidence rate of bacterial infection was 56.7%. Among these 609 patients, 16 underwent liver transplantation within 90 days and related data statistics were obtained for the remaining 593 patients. As for infection site, among the patients with infection, 70.15% had abdominal infection, 41.15% had pulmonary infection, 11.97% had sepsis, 5.40% had urinary system infection, 4.89% had thoracic infection, and 8.6% had infection at other sites. Among the patients with infection, 64.76% had infection at a single site. The positive rates of microbial culture of ascites, phlegm, urine, and pleural effusion were 22.70%, 52.82%, 40.63%, and 35.71%, respectively. Escherichia coli was the most common bacterium in ascites and accounted for 43.82%; Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii accounted for 22.67%, 24.00%, and 22.67%, respectively, in phlegm; Escherichia coli, Klebsiella pneumoniae, and Staphylococcaceae accounted for 33.80%, 29.58%, and 15.49%, respectively, in blood culture. The 90-day survival rate after infection was 38.11% (226/593) in the patients with ACLF, and the multivariate logistic regression analysis showed that age (P=0.006), stage of hepatic encephalopathy (HE) (P < 0.001), stage of liver failure (P < 0.001), and acute kidney injury (AKI) (P < 0.001) were independent risk factors for 90-day survival in patients with ACLF and infection.  Conclusion  There is a high incidence rate of infection in patients with ACLF. The 90-day survival rate is relatively low, and the presence of AKI, HE stage III or above, and advanced liver failure may indicate poor prognosis.

     

    • FullText(HTML)
  • loading
    • References(14)
  • [1]
    LIU XY, CHEN J, TONG JJ, et al. The causes of death and clinical characteristic of patients with HBV-ACLF[J]. Chin J Hepatol, 2015, 23(9): 704-706. DOI: 10.3760/cma.j.issn.1007-3418.2015.09.015.

    刘晓燕, 陈婧, 童晶晶, 等. 393例乙型肝炎病毒相关慢加急性肝衰竭死亡患者死因及临床特征分析[J]. 中华肝脏病杂志, 2015, 23(9): 704-706. DOI: 10.3760/cma.j.issn.1007-3418.2015.09.015.
    [2]
    BAJAJ JS, O'LEARY JG, REDDY KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures[J]. Hepatology, 2014, 60(1): 250-256. DOI: 10.1002/hep.27077.
    [3]
    MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144(7): 1426-1437. DOI: 10.1053/j.gastro.2013.02.042.
    [4]
    Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, CMA. Guideline for diagnosis and treatment of liver failure (2012 version)[J]. Chin J Clin Infect Dis, 2012, 5(6): 321-327. DOI: 10.3760/cma.j.issn.1674-2397.2012.06.001.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 中华临床感染病杂志, 2012, 5(6): 321-327. DOI: 10.3760/cma.j.issn.1674-2397.2012.06.001.
    [5]
    Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.

    中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
    [6]
    ANGELI P, GINÈS P, WONG F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites[J]. J Hepatol, 2015, 62(4): 968-974. DOI: 10.1016/j.jhep.2014.12.029.
    [7]
    Society of Infectious Diseases, Chinese Medical Association. Expert consensus on diagnosis and treatment of end-stage liver disease complicated with infections[J]. J Clin Hepatol, 2018, 34(9): 1862-1872. DOI: 10.3969/j.issn.1001-5256.2018.09.008.

    中华医学会感染病学分会. 终末期肝病合并感染诊治专家共识[J]. 临床肝胆病杂志, 2018, 34(9): 1862-1872. DOI: 10.3969/j.issn.1001-5256.2018.09.008.
    [8]
    FERNÁNDEZ J, ACEVEDO J, WIEST R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: Prevalence, characteristics and impact on prognosis[J]. Gut, 2018, 67(10): 1870-1880. DOI: 10.1136/gutjnl-2017-314240.
    [9]
    ARVANITI V, D'AMICO G, FEDE G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis[J]. Gastroenterology, 2010, 139(4): 1246-1256. DOI: 10.1053/j.gastro.2010.06.019.
    [10]
    JALAN R, FERNANDEZ J, WIEST R, et al. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013[J]. J Hepatol, 2014, 60(6): 1310-1324. DOI: 10.1016/j.jhep.2014.01.024.
    [11]
    BAJAJ JS, O'LEARY JG, TANDON P, et al. Hepatic encephalopathy is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures[J]. Clin Gastroenterol Hepatol, 2017, 15(4): 565-574. DOI: 10.1016/j.cgh.2016.09.157.
    [12]
    LIU XY, XIN SJ, CHEN J, et al. Significance of liver failure staging in predicting the prognosis of HBV-acute-on-chronic liver failure[J]. Acad J Chin PLA Med Sch, 2014, 35(6): 521-524, 544. DOI: 10.3969/j.issn.2095-5227.2014.06.001.

    刘晓燕, 辛绍杰, 陈婧, 等. 肝衰竭分期对HBV感染慢加急性肝衰竭预后判断的意义[J]. 解放军医学院学报, 2014, 35(6): 521-524, 544. DOI: 10.3969/j.issn.2095-5227.2014.06.001.
    [13]
    GUPTA S, JASWANI P, SHARMA RK, et al. Procalcitonin as a diagnostic biomarker of sepsis: A tertiary care centre experience[J]. J Infect Public Health, 2019, 12(3): 323-329. DOI: 10.1016/j.jiph.2018.11.004.
    [14]
    CHOI JJ, MCCARTHY MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018, 18(1): 27-34. DOI: 10.1080/14737159.2018.1407244.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (532) PDF downloads(57) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return